Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03246087 · ClinicalTrials.gov registry record · NA

Acupuncture for Plantar Fasciosis in the Primary Care Setting

A NA study of Plantar Fascitis, sponsored by Mike O'Callaghan Military Hospital.

Completed
Registry status
NA
Development phase
94
Enrollment target
2
Study locations

NCT03246087: Completed NA study of Plantar Fascitis, sponsored by Mike O'Callaghan Military Hospital.

NCT03246087 is a NA study of Plantar Fascitis that has completed, run by Mike O'Callaghan Military Hospital. The registered enrollment target is 94 participants, above the 82-participant average among 7 other Plantar Fascitis trials with a reported enrollment target (15% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03246087, a NA study of Plantar Fascitis, has completed, sponsored by Mike O'Callaghan Military Hospital.

COMPLETED
Registry status
NA
Development phase
94 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to determine if the addition of acupuncture to a standard of care prescribed exercise program is more effective at improving pain and function in adult patients with plantar fasciosis.

Primary Outcome

Numeric Pain Rating Scale. 11 point numeric rating on a scale of 0-10 to measure pain intensity. 0 being no pain, 5 being moderate pain, and 10 being worst pain.

Conditions Studied

Interventions

  • OTHER Standard of care
  • DEVICE Acupunture

Study Locations (2)

Illinois

  • Scott AFB - Belleville

Nevada

  • Mike O'Callaghan Federal Hospital - Nellis Air Force Base

Trial Details

FieldValue
Enrollment Target 94 participants
Start Date 2017-10-17
Est. Completion 2019-04-13
Phase NA
Mike O'Callaghan Military Hospital

26 total trials

What the finished NCT03246087 record still lists

NCT03246087 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 94 participants, a relatively small participant target, above the 82-participant average among 7 other Plantar Fascitis trials with a reported enrollment target (15% higher).

The record links to 1 condition, with Plantar Fascitis appearing as the primary indexed condition, and to 2 interventions - of which Standard of care is the first listed.

NCT03246087 reports a single indexed study location in Illinois, Nevada.

Frequently Asked Questions

What is clinical trial NCT03246087 about?

NCT03246087 is a clinical study titled "Acupuncture for Plantar Fasciosis in the Primary Care Setting". The purpose of this study is to determine if the addition of acupuncture to a standard of care prescribed exercise program is more effective at improving pain and function in adult patients with plantar fasciosis.

What is the current status of trial NCT03246087?

This trial is currently completed. It is a NA study. The enrollment target is 94 participants. The study started on 2017-10-17. Estimated completion is 2019-04-13.

What conditions does trial NCT03246087 study?

This clinical trial studies the following conditions: Plantar Fascitis.

What interventions are being tested in trial NCT03246087?

The interventions under investigation include: Standard of care (OTHER), Acupunture (DEVICE).

Who is sponsoring clinical trial NCT03246087?

This trial is sponsored by Mike O'Callaghan Military Hospital, which has 26 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03246087 being conducted?

This trial has 2 study locations across Illinois, Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Plantar Fascitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03747146 · 94 participants · NA

    Enhanced Recovery After Surgery (ERAS) Total Knee Replacement (TKR) With a Transitional Pain Service

  • NCT04061421 · 94 participants · Phase 1

    Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)

  • NCT04205968 · 94 participants · Phase 2

    Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers

  • NCT04464759 · 94 participants · Phase 1

    A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03246087, the US trial registry maintained by the National Library of Medicine. NCT03246087 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.